Merkliste 
 1 Ergebnisse 
 
1

BTKi, venetoclax, obinutuzumab: what is the ideal combinati..:

Heintel, Daniel
memo - Magazine of European Medical Oncology.  15 (2021)  1 - p. 49-52 , 2021